Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma

By Yang Q-F.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 3, 2000-06 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma

By Olumi A.F.   Weidner N.   Presti J.C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 2, 2001-03 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite

Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer

By Hosoda Mitsuchika   Yamamoto Mitsugu   Nakano Kiichiroh   Hatanaka Kanako   Takakuwa Emi   Hatanaka Yutaka   Matsuno Yoshihiro   Yamashita Hiroko  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 249-261

Springer Publishing Company

Access to resources Recommend Favorite

Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas

By Tufail Rozina  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 743-750

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of p53 and Bcl-2 Expression as Prognostic Markers in Invasive Cervical Carcinoma Stage IIb/III Patients Treated by Radiotherapy

By Jain D.   Srinivasan R.   Patel F.D.   Kumari Gupta S.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 22-28

Academic Press

Access to resources Recommend Favorite